Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriers

Leendert H. Zaaijer, Helena C. van Doorn, Marian J. E. Mourits, Marc van Beurden, Joanne A. de Hullu, Muriel A. Adank, Luc R. C. W. van Lonkhuijzen, Hans F. A. Vasen, Brigitte F. M. Slangen, Katja N. Gaarenstroom, Ronald P. Zweemer, Peggy M. L. H. Vencken, Caroline Seynaeve, Mieke Kriege*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1174-1178
JournalBritish Journal of Cancer
Volume115
Issue number10
DOIs
Publication statusPublished - 8 Nov 2016

Keywords

  • BRCA mutation
  • breast cancer
  • ovarian cancer
  • survival
  • chemotherapy

Cite this